By Most people think about health in terms of how they feel. Metabolic health works differently – it’s about what’s happening inside the body’s fundamental regulatory systems, most of which produce no symptoms until they’ve been disrupted for years. By the time metabolic dysfunction starts to feel like something, significant physiological groundwork for chronic disease has typically already been laid.
The striking statistic: only about 12% of American adults are considered metabolically healthy by all five key criteria, according to research published in Metabolic Syndrome and Related Disorders. That means 88% of American adults have at least one marker of metabolic dysfunction – most without knowing it.
Understanding metabolic health means understanding five specific, measurable numbers and what they actually represent.
What Metabolic Health Is
Metabolic health describes how efficiently the body manages energy – specifically, how well it regulates blood glucose, blood fats, blood pressure, and body fat distribution. These processes are interconnected through a web of hormonal and cellular pathways, with insulin signaling at the center.
When these systems work properly:
- Cells respond efficiently to insulin’s signals, allowing glucose to move from blood into cells after meals
- Blood glucose rises modestly after eating and returns to normal within a couple of hours
- The liver processes fats efficiently and doesn’t accumulate excess fat itself
- Blood pressure stays within healthy ranges without medication
- Body fat is distributed in ways that don’t impose excessive metabolic burden
When metabolic health is compromised – a state called metabolic syndrome or metabolic dysfunction – these processes become dysregulated in ways that dramatically increase risk of type 2 diabetes, cardiovascular disease, fatty liver disease, certain cancers, cognitive decline, and all-cause mortality.
The Five Criteria for Metabolic Health
Metabolic syndrome is formally defined by the presence of three or more of the following five criteria (using the harmonized international definition, which is also used in the US):
1. Waist Circumference
Elevated: Above 40 inches (102 cm) for men; above 35 inches (88 cm) for women (Lower thresholds apply for South Asian, East Asian, and some other ethnic groups)
Waist circumference measures visceral adiposity – the fat stored deep in the abdominal cavity around the internal organs. This is metabolically very different from subcutaneous fat (fat stored under the skin, which you can pinch).
Visceral fat is metabolically active in harmful ways: it secretes inflammatory cytokines, releases free fatty acids directly into the portal circulation (which flows to the liver), overactivates the RAAS (raising blood pressure), and impairs insulin signaling in surrounding tissues. High visceral fat is independently predictive of cardiovascular disease, type 2 diabetes, and mortality even in people with normal total body weight – a phenomenon called “normal-weight obesity” or TOFI (Thin Outside, Fat Inside).
Waist circumference is a better predictor of metabolic risk than BMI because it specifically captures visceral fat distribution. Measuring it takes 30 seconds with a tape measure: measure at the level of the navel (not the narrowest point of the waist), without holding your breath.
2. Fasting Blood Glucose
Elevated: 100 mg/dL (5.6 mmol/L) or above, or currently on diabetes medication
Fasting blood glucose – measured after at least 8 hours without eating – reflects the liver’s overnight glucose production and the efficiency of insulin-mediated glucose regulation. Glucose above 100 mg/dL on fasting (impaired fasting glucose or prediabetes range) indicates the regulatory system is under strain.
The formal prediabetes range is 100-125 mg/dL fasting or HbA1c 5.7-6.4%. Type 2 diabetes is diagnosed at 126+ mg/dL fasting on two occasions, or HbA1c 6.5%+.
HbA1c complements fasting glucose for metabolic assessment – it reflects average blood glucose over the preceding 3 months rather than a single moment, making it less susceptible to day-to-day variation. An HbA1c of 5.4-5.6% is increasingly recognized as a zone of elevated risk even before the formal 5.7% prediabetes threshold.
3. Blood Pressure
Elevated: 130/85 mmHg or above, or currently on blood pressure medication
Sustained elevated blood pressure reflects vascular dysfunction – reduced arterial elasticity, endothelial damage, and often increased fluid volume from RAAS overactivation. In the metabolic health context, hypertension typically reflects downstream effects of insulin resistance: insulin normally promotes vasodilation and sodium excretion; when insulin resistance is present, these effects are blunted and blood pressure rises.
The 130/85 threshold used in metabolic syndrome criteria is lower than the formal hypertension diagnosis threshold (130/80 for Stage 1) – recognizing that within the metabolic syndrome framework, even this modestly elevated range signals cardiovascular risk when clustered with other criteria.
4. Triglycerides
Elevated: 150 mg/dL (1.7 mmol/L) or above, or on lipid-lowering medication for triglycerides
Triglycerides – the fats circulating in the bloodstream – are elevated when the liver is producing excessive amounts, typically driven by high refined carbohydrate and sugar intake alongside insulin resistance. A high fasting triglyceride level is one of the strongest single markers of insulin resistance and metabolic dysfunction.
Normal fasting triglycerides: below 150 mg/dL Borderline high: 150-199 mg/dL High: 200-499 mg/dL Very high (pancreatitis risk): 500+ mg/dL
Triglycerides are best measured fasting (at least 8 hours) because a recent meal significantly elevates them transiently. A non-fasting triglyceride above 200 mg/dL is clinically significant and warrants fasting repeat.
The triglyceride:HDL ratio is particularly informative – a ratio above 3.5 (mg/dL units) strongly suggests insulin resistance and small dense LDL particle predominance, even when LDL appears “normal” on a standard lipid panel. This ratio is one of the most useful and underutilized markers in metabolic health assessment.
5. HDL Cholesterol
Low: Below 40 mg/dL (1.0 mmol/L) for men; below 50 mg/dL (1.3 mmol/L) for women
HDL – high-density lipoprotein – is involved in reverse cholesterol transport, carrying cholesterol from peripheral tissues back to the liver for processing. Low HDL is a marker of metabolic dysfunction and cardiovascular risk, and is characteristically low in the context of insulin resistance and elevated triglycerides.
The relationship between HDL and cardiovascular risk is more complex than “higher is always better” – very high HDL levels (above 90-100 mg/dL) are not straightforwardly protective and may in some cases reflect dysfunctional HDL particles. But low HDL, particularly in the context of elevated triglycerides (the classic dyslipidemia of insulin resistance), is a meaningful risk marker.
Triglycerides and HDL are the lipid values most closely reflecting metabolic health and insulin sensitivity. A pattern of high triglycerides + low HDL is far more informative about metabolic risk than LDL cholesterol alone – yet LDL gets the lion’s share of attention in standard cardiovascular risk discussions.
The Clustering Effect: Why Having Multiple Abnormal Values Multiplies Risk
Metabolic syndrome is diagnosed when three or more criteria are met – but the reason the clustering matters is that these five abnormalities are not independent risk factors that simply add together. They multiply risk.
The combination of elevated blood glucose + elevated triglycerides + low HDL + elevated waist circumference + elevated blood pressure produces a cardiovascular and diabetes risk that is substantially greater than the sum of each factor individually. People with full metabolic syndrome have:
- Approximately 2-fold increased risk of cardiovascular disease
- 5-fold increased risk of type 2 diabetes
- Significantly increased risk of fatty liver disease (MASLD), chronic kidney disease, sleep apnea, and certain cancers
The underlying driver connecting all five criteria is insulin resistance – not a coincidence, but a shared physiological mechanism producing downstream effects across multiple organ systems simultaneously.
Beyond the Five: Additional Markers Worth Knowing
The five metabolic syndrome criteria are the formal clinical definition, but additional markers provide a more complete picture of metabolic health:
Fasting insulin: Not routinely included in standard metabolic syndrome criteria but arguably more sensitive than fasting glucose for detecting early insulin resistance. Insulin resistance typically causes hyperinsulinemia (elevated insulin) years before fasting glucose rises. Many practitioners use HOMA-IR (Homeostatic Model Assessment of Insulin Resistance), calculated from fasting glucose and insulin, to quantify insulin resistance. This requires fasting insulin testing, which isn’t always ordered routinely.
HbA1c: As noted above, provides a 3-month average blood glucose and catches dysregulation not apparent on fasting glucose alone.
Uric acid: Often elevated in metabolic syndrome, particularly when high fructose intake drives hepatic uric acid production alongside triglycerides. Elevated uric acid is also independently associated with hypertension, gout, and cardiovascular disease.
High-sensitivity CRP (hs-CRP): A sensitive marker of systemic inflammation. Metabolic syndrome is an inflammatory state, and elevated hs-CRP (above 1 mg/L, particularly above 3 mg/L) indicates cardiovascular risk. The JUPITER trial demonstrated that statin therapy in people with normal LDL but elevated hs-CRP significantly reduced cardiovascular events.
Liver enzymes (ALT, AST): Elevated in metabolic-associated fatty liver disease (MASLD), which is present in approximately 75-90% of people with metabolic syndrome. However, liver enzymes are normal in up to 80% of NAFLD cases, so normal enzymes don’t rule out fatty liver.
What Drives Metabolic Dysfunction
The root causes of metabolic syndrome are multifactorial – it’s the intersection of genetic predisposition and environmental/lifestyle factors:
Dietary patterns: High intake of refined carbohydrates, added sugars (particularly fructose), ultra-processed foods, and excess total calories drives insulin resistance, hepatic fat accumulation, and dyslipidemia. The Mediterranean dietary pattern has the strongest evidence for improving metabolic syndrome components.
Physical inactivity: Skeletal muscle is the primary site of insulin-stimulated glucose disposal. Inadequate physical activity – both aerobic exercise and strength training – impairs this system.
Visceral fat accumulation: The consequence of excess energy balance over time, particularly with dietary patterns promoting hepatic fat deposition.
Poor sleep: Sleep deprivation and sleep disorders (particularly obstructive sleep apnea) impair glucose metabolism, elevate cortisol, increase appetite-stimulating hormones (ghrelin), and worsen insulin resistance. Short sleep duration is independently associated with metabolic syndrome.
Chronic stress: Sustained cortisol elevation promotes visceral fat deposition, raises blood glucose (cortisol is gluconeogenic), and raises blood pressure.
Genetic susceptibility: Some individuals develop metabolic syndrome at lower body weights than others due to genetic differences in fat distribution, insulin sensitivity, and lipid metabolism.
What Improves Metabolic Health
Metabolic syndrome is largely reversible through lifestyle intervention, particularly in early stages. The evidence-supported interventions:
Weight loss: Even modest weight loss (5-10% of body weight) significantly improves all five metabolic syndrome components. Visceral fat is preferentially lost with caloric restriction and exercise, even before total body weight changes substantially.
Exercise: Both aerobic exercise and resistance training improve insulin sensitivity, lower triglycerides, raise HDL, reduce blood pressure, and reduce visceral adiposity. The combination is more effective than either alone. Even short post-meal walks significantly blunt postprandial glucose spikes.
Dietary changes: Reducing refined carbohydrates and added sugars, increasing fiber (particularly from legumes), adopting Mediterranean-style eating, and reducing ultra-processed food consumption all improve metabolic markers.
Sleep optimization: Addressing poor sleep – whether through behavioral changes or treating sleep apnea – improves glucose metabolism, reduces appetite dysregulation, and reduces cortisol-driven metabolic effects.
Stress management: Chronic stress management through exercise, mindfulness, adequate social support, and sleep reduces the cortisol burden that contributes to metabolic dysfunction.
Medications where appropriate: Metformin for prediabetes/diabetes, statins for cardiovascular risk, antihypertensives for blood pressure, fibrates or omega-3s for very high triglycerides. These address specific components but work best alongside lifestyle change.
Frequently Asked Questions
I have one of the five criteria – do I have metabolic syndrome? No – metabolic syndrome requires three or more criteria. Having one is a signal to monitor and address the underlying risk factors before others develop. The trajectory matters as much as the current number – a waist circumference or blood pressure that’s rising over years deserves attention even before it crosses the formal threshold.
Can thin people have metabolic syndrome? Yes – and this is clinically important. “Normal-weight obesity” or TOFI (Thin Outside, Fat Inside) describes people with normal BMI but high visceral fat relative to lean mass – and they can meet multiple metabolic syndrome criteria despite appearing lean. Waist circumference is more informative than weight alone. Certain ethnic groups (particularly South and East Asian populations) develop metabolic complications at lower BMIs, which is why ethnic-specific waist circumference thresholds exist.
Is metabolic syndrome the same as diabetes? No – metabolic syndrome is a clustering of risk factors that substantially increases the risk of developing type 2 diabetes, but many people with metabolic syndrome do not have diabetes at diagnosis. However, up to 50% of people with metabolic syndrome will develop type 2 diabetes over 5-10 years without intervention.
How often should these five values be checked? If all five are normal and you have no significant risk factors, checking every 2-3 years is reasonable for most values. Blood pressure should be checked annually in adults. If any values are abnormal or borderline, more frequent monitoring (annually or more) is appropriate. Your healthcare provider can advise based on your specific picture.
Can metabolic syndrome be fully reversed? In many cases, yes – particularly when addressed early. The Diabetes Prevention Program showed that lifestyle intervention can prevent progression from prediabetes to diabetes even in people who meet multiple metabolic syndrome criteria. Significant weight loss in people with early metabolic syndrome routinely normalizes all five criteria. Even in established metabolic syndrome, meaningful improvement in all markers is achievable with sustained lifestyle change.
Disclaimer
This article is for educational purposes only and does not constitute medical advice. Metabolic health assessment and management should be guided by a qualified healthcare provider. Do not make medication decisions or major health interventions based solely on this content.
References
- Araújo J, Cai J, Stevens J. Prevalence of optimal metabolic health in American adults: National Health and Nutrition Examination Survey 2009-2016. Metabolic Syndrome and Related Disorders. 2019;17(1):46-52. https://doi.org/10.1089/met.2018.0105
- Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement. Circulation. 2009;120(16):1640-1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
- Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an AHA/NHLBI scientific statement. Circulation. 2005;112(17):2735-2752. https://doi.org/10.1161/CIRCULATIONAHA.105.169404
- Knowler WC, et al. Reduction in incidence of type 2 diabetes with lifestyle intervention (DPP). New England Journal of Medicine. 2002;346(6):393-403. https://doi.org/10.1056/NEJMoa012512
- Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. The Lancet. 2005;365(9468):1415-1428. https://doi.org/10.1016/S0140-6736(05)66378-7
- Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein (JUPITER trial). New England Journal of Medicine. 2008;359(21):2195-2207. https://doi.org/10.1056/NEJMoa0807646
- Tchernof A, Després JP. Pathophysiology of human visceral obesity. Physiological Reviews. 2013;93(1):359-404. https://doi.org/10.1152/physrev.00033.2011
- American Heart Association. Metabolic syndrome. https://www.heart.org/en/health-topics/metabolic-syndrome
- National Heart, Lung, and Blood Institute (NHLBI). Metabolic syndrome. https://www.nhlbi.nih.gov/health/metabolic-syndrome
- Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881-887. https://doi.org/10.1038/nature05488
